Generate Biomedicines, Inc. (GENB) reporting calendar
Generate Biomedicines, Inc. files periodic reports with the SEC as GENB on Nasdaq. Atlas tracks 1 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 1
Open GENB market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001193125-26-210059 |
Source: SEC EDGAR company submissions for CIK 0002100782. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.